Time sequence of the intensification of the liver glucose production induced by high-fat diet in mice

Cell Biochemistry and Function

Volumn 30, Issue 4, 2012, Pages 335-339

  Obici, Simoni ^a   Tavoni, Thauany Martins ^a   Barrena, Helenton C ^a   Curi, Rui ^b   Bazotte, Roberto B ^a  

^a STATE UNIVERSITY OF MARINGÁ   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

High fat diet; Hyperglycaemia; Insulin resistance; Liver gluconeogenesis

Indexed keywords

ALANINE; CHOLESTEROL; GLUCOSE; GLUTAMINE; GLYCEROL; LACTIC ACID; PYRUVIC ACID; TRIACYLGLYCEROL; UREA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOLOGICAL RHYTHM; BODY FAT; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET RESTRICTION; EPIDIDYMIS; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; HYPERCHOLESTEROLEMIA; INGUINAL REGION; LIPID DIET; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RETROPERITONEUM; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; CHOLESTEROL; DIET, HIGH-FAT; GLUCONEOGENESIS; GLUCOSE; INSULIN RESISTANCE; LIVER; MALE; MICE; TIME FACTORS; TRIGLYCERIDES;

MUS;

EID: 84861949901     PISSN: 02636484     EISSN: 10990844     Source Type: Journal    
DOI: 10.1002/cbf.2809     Document Type: Article

References (32)

1. Han D, Hansen PA, Host HH, Holloszy JO. Insulin resistance of muscle glucose transport in rats fed a high-fat diet: a reevaluation. Diabetes 1997; 46: 1761-1767. doi:10.2337/diabetes.46.11.1761.
2. Buettner R, Parhofer KG, Woenckhaus M, et al. Defining high-fat-diet rat models: metabolic and molecular effects of different fat types. J Mol Endocrinol 2006; 36: 485-501. doi:10.1677/jme.1.01909.
3. Kim SP, Ellmerer M, Van Citters GW, Bergman RN. Primacy of hepatic insulin resistance in the development of the metabolic syndrome induced by an isocaloric moderate-fat diet in the dog. Diabetes 2003; 52: 2453-2460. doi:10.2337/diabetes.52.10.2453.
4. Samuel VT, Liu ZX, Qu X, et al. Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease. J Biol Chem 2004; 279: 32345-32353. doi:10.1074/jbc.M313478200.
5. De Fraia Pinto LF, Compri CM, Fornari JV, et al. he immunosuppressant drug, thalidomide, improves hepatic alterations induced by a high-fat diet in mice. Liver Int 2010; 30: 603-610. doi:10.1111/j.1478-3231.2009.02200.x.
6. Gao D, Nong S, Huang X, et al. The effects of palmitate on hepatic insulin resistance are mediated by NADPH Oxidase 3-derived reactive oxygen species through JNK and p38MAPK pathways. J Biol Chem 2010; 285: 29965-29973. doi:10.1074/jbc.M110.128694.
7. Jump DB. Fatty acid regulation of hepatic lipid metabolism. Curr Opin Clin Nutr Metab Care 2011; 14: 115-120. doi:10.1097/MCO.0b013e328342991c.
8. Tanner JM, Kearns DT, Kim BJ, et al. Fasting-induced reductions in cardiovascular and metabolic variables occur sooner in obese versus lean mice. Exp Biol Med 2010; 235: 1489-1497. doi:10.1258/ebm.2010.010171.
9. Takemura N, Okubo T, Sonoyama K. Lactobacillus plantarum strain No. 14 reduces adipocyte size in mice fed high-fat diet. Exp Biol Med 2010; 235: 849-856. doi:10.1258/ebm.2010.009377.
10. Tsukumo DM, Carvalho-Filho MA, Carvalheira JB, et al. Loss-of-function mutation in Toll-like receptor 4 prevents diet-induced obesity and insulin resistance. Diabetes 2007; 56: 1986-1998. doi:10.2337/db06-1595.
11. Romanatto T, Roman EA, Arruda AP, et al. Deletion of tumor necrosis factor-alpha receptor 1 (TNFR1) protects against diet-induced obesity by means of increased thermogenesis. J Biol Chem 2009; 284: 36213-36222. doi:10.1074/jbc.M109.030874.
12. Gallagher EJ, Leroith D, Karnieli E. Insulin resistance in obesity as the underlying cause for the metabolic syndrome. Mt Sinai J Med 2010; 77: 511-523. doi:10.1002/msj.20212.
13. Unger J, Parkin CG. Type 2 diabetes: an expanded view of pathophysiology and therapy. Postgrad Med 2010; 122: 145-157. doi:10.3810/pgm.2010.05.2152.
14. Araújo EP, De Souza CT, Ueno M, et al. Infliximab restores glucose homeostasis in an animal model of diet-induced obesity and diabetes. Endocrinology 2007; 148: 5991-5997. doi:10.1210/en.2007-0132.
15. Bergmeyer HU, Bernt E. Determination of glucose with glucoseoxidase and peroxidase. In Methods of Enzymatic Analysis, Bergmeyer HU (ed.). Academic Press: Weinhein, London, 1974; 1205-1215.
16. Allain CC, Poon LS, Chan CS, Richmond W, Fu PC. Enzymatic determination of total serum cholesterol. Clin Chem 1974; 20: 470-475.
17. Bucolo G, David H. Quantitative determination of serum triglycerides by the enzymes. Clin Chem 1973; 19: 476-482.
18. Obici S, Lopes-Bertolini G, Curi R, Bazotte RB. Liver glycogen metabolism during short-term insulin-induced hypoglycemia in fed rats. Cell Biochem Funct 2008; 26: 755-759. doi:10.1002/cbf.1501.
19. Schiavon FPM, Gazola VAFG, Furlan MMDP, Barrena HC, Bazotte RB. Paradoxical increase in liver ketogenesis during long-term insulin-induced hypoglycemia in diabetic rats. Exp Biol Med 2011; 236: 227-232. doi:10.1258/ebm.2010.010266.
20. Gutmann I, Wahlefeld AW. l-(+)-Lactate. Determination with lactate dehydrogenase and NAD. In Methods of Enzymatic Analysis, Bergmeyer HU (ed.). Academic Press: Weinhein, London, 1974; 1464-1468.
21. Czok R, Lamprecht W. Pyruvate, phosphoenolpyruvate and D-glycerate-2-phosphate. In Methods of Enzymatic Analysis, Bergmeyer HU (ed.). Academic Press: Weinhein, London, 1974; 1446-1451.
22. Gutmann I, Bergmeyer HU. Determination of urea, indicator reaction with phenol and hypochlorite. In Methods of Enzymatic Analysis, Bergmeyer HU (ed.). Academic Press: Weinhein, London, 1974; 1790-1798.
23. Conti R, Mannucci E, Pessotto P, et al. Selective reversible inhibition of liver carnitine palmitoyl-transferase 1 by teglicar reduces gluconeogenesis and improves glucose homeostasis. Diabetes 2011; 60: 644-651. doi:10.2337/db10-0346.
24. Garcia RF, Gazola VAFG, Barrena HC, et al. Blood amino acids concentration during insulin induced hypoglycemia in rats: the rule of alanine and glutamine to glucose recovery. Amino Acids 2007; 33: 151-155. doi:10.1007/s00726-006-0397-8.
25. Newsholme P, Abdulkader F, Rebelato E, et al. Amino acids and diabetes: implications for endocrine, metabolic and immune function. Front Biosci 2011; 16: 315-339doi:.
26. Pinheiro CH, Silveira LR, Nachbar RT, Vitzel KF, Curi R. Regulation of glycolysis and expression of glucose metabolism-related genes by reactive oxygen species in contracting skeletal muscle cells. Free Radic Biol Med 2010; 48: 953-960. doi:10.1016/j.freeradbiomed.2010.01.016.
27. Geisler AS, Felisberto-Junior AM, Tavoni TM, Carrara MA, Curi R, Bazotte RB. Participation of the liver gluconeogenesis in the glibenclamide-induced hypoglycaemia in rats. Cell Biochem Funct 2011; 29: 81-86. doi:10.1002/cbf.1722.
28. Prada PO, Zecchin HG, Gasparetti AL, et al. Western diet modulates insulin signaling, c-Jun N-Terminal kinase activity, and insulin receptor substrate-1ser307 phosphorylation in a tissue-specific fashion. Endocrinology 2005; 146: 1576-1587. doi:10.1210/en.2004-0767.
29. Kraegen EW, Clark PW, Jenkins AB, Daley EA, Chisholm DJ, Storlien LH. Development of muscle insulin resistance after liver insulin resistance in high-fat-fed rats. Diabetes 1991; 40: 1397-1403. doi:10.2337/diabetes.40.11.1397.
30. Bugianesi E, Moscatiello S, Ciaravella MF, Marchesini G. Insulin resistance in nonalcoholic fatty liver disease. Curr Pharm Des 2010; 16: 1941-1951. doi:10.2174/138161210791208875.
31. DeFronzo RA. Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links. The Claude Bernard Lecture 2009. Diabetologia 2010; 53: 1270-1287. doi:10.1007/s00125-010-1684-1.
32. Tsugane S, Inoue M. Insulin resistance and cancer: epidemiological evidence. Cancer Sci 2010; 101: 1073-1079. doi:10.1111/j.1349-7006.2010.01521.x.